[go: up one dir, main page]

ATE99938T1 - Vaginalsuppositorium. - Google Patents

Vaginalsuppositorium.

Info

Publication number
ATE99938T1
ATE99938T1 AT90101245T AT90101245T ATE99938T1 AT E99938 T1 ATE99938 T1 AT E99938T1 AT 90101245 T AT90101245 T AT 90101245T AT 90101245 T AT90101245 T AT 90101245T AT E99938 T1 ATE99938 T1 AT E99938T1
Authority
AT
Austria
Prior art keywords
vaginal suppository
suppository
dhas
vagina
plus
Prior art date
Application number
AT90101245T
Other languages
English (en)
Inventor
Minoru Sakaguchi
Norio Awata
Tsuneo Kawashima
Hiroshi Nakagawa
Original Assignee
Kanebo Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kanebo Ltd filed Critical Kanebo Ltd
Application granted granted Critical
Publication of ATE99938T1 publication Critical patent/ATE99938T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/02Suppositories; Bougies; Bases therefor; Ovules
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183Amino acids, e.g. glycine, EDTA or aspartame
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0034Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
AT90101245T 1989-01-23 1990-01-22 Vaginalsuppositorium. ATE99938T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP1014528A JP2546808B2 (ja) 1989-01-23 1989-01-23 膣坐剤

Publications (1)

Publication Number Publication Date
ATE99938T1 true ATE99938T1 (de) 1994-01-15

Family

ID=11863637

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90101245T ATE99938T1 (de) 1989-01-23 1990-01-22 Vaginalsuppositorium.

Country Status (7)

Country Link
EP (1) EP0380036B1 (de)
JP (1) JP2546808B2 (de)
AT (1) ATE99938T1 (de)
DE (1) DE69005834T2 (de)
DK (1) DK0380036T3 (de)
ES (1) ES2062117T3 (de)
PT (1) PT92940B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH09323934A (ja) * 1996-05-31 1997-12-16 Kanebo Ltd 保存安定性の改善された坐剤
FR2815860B1 (fr) * 2000-10-26 2003-12-12 Oreal Composition, notamment cosmetique, comprenant la dhea et/ou precurseur ou derive de celle-ci et au moins un agent myorelaxant
WO2006089561A1 (en) * 2005-02-23 2006-08-31 Abbas Abdelsalam Ghazi Pharmaceutical compositions containing organic acids useful for softening and ripening uterine cervix.
JP5659407B2 (ja) * 2010-11-01 2015-01-28 株式会社サイエンスリン 経皮吸収促進性皮膚外用剤

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE439586B (sv) * 1975-09-05 1985-06-24 Kanebo Ltd Sett att framstella ett stabilt farmaceutiskt torrpreparat av ett alkalimetallsalt av dehydroepiandrosteronsulfat
JPS56118013A (en) * 1980-02-25 1981-09-16 Teijin Ltd Calcitonin pharmaceutical and its preparation
JPS5767513A (en) * 1980-10-14 1982-04-24 Asahi Chem Ind Co Ltd Novel drug composition for rectal administration
JPS5788113A (en) * 1980-11-19 1982-06-01 Morishita Seiyaku Kk Rectum medication composition
JPS57138115A (en) * 1981-02-20 1982-08-26 Tokyo Electric Co Ltd Coil
JPS63104924A (ja) * 1986-10-20 1988-05-10 Kanebo Ltd 膣坐剤

Also Published As

Publication number Publication date
PT92940A (pt) 1990-07-31
JP2546808B2 (ja) 1996-10-23
ES2062117T3 (es) 1994-12-16
DE69005834T2 (de) 1994-05-05
JPH02193925A (ja) 1990-07-31
EP0380036A2 (de) 1990-08-01
EP0380036A3 (en) 1990-12-05
EP0380036B1 (de) 1994-01-12
PT92940B (pt) 1995-11-30
DE69005834D1 (de) 1994-02-24
DK0380036T3 (da) 1994-02-14

Similar Documents

Publication Publication Date Title
ATE62606T1 (de) Medizinisches rohr.
YU47800B (sr) Estri tienil-karboksilne kiseline sa aminoalkoholima, njihova kvaterna jedinjenja kao i pripremanje tih jedinjenja
EP0338813A3 (de) Hyaluronsäure enthaltende wässerige Lösung oder wässerige Kollagendispersion
EP0429430A3 (en) Expectorants comprising n-acetylneuraminic acid
GR3019514T3 (en) Pharmaceutical preparation for the treatment of prolonged coagulation time
DE3770571D1 (de) Vaginalsuppositorium.
EP0205334A3 (de) Benzazepinderivate
MY103210A (en) Arylpiperazinyl-alkylene-phenyl-heterocyclic compounds.
ATE99938T1 (de) Vaginalsuppositorium.
EP0378824A3 (en) Use of omega-3-fatty acids as anticachexia agents
IL103799A (en) Fish production
MY106036A (en) Preventing agent for human immunodeficiency virus infection comprising menfegol.
WO1991015466A3 (en) Aminopolycarboxylic acid chelating agents
OA08730A (fr) Tampon en éponge élastique, notamment tampon vaginal.
ES2015896B3 (es) Sal de una morfolina sustituida con acido fluoborico y agente para la proteccion de la madera.
FR2603284B1 (fr) Derives d'acide 7-oxabicyclo(2.2.1.)heptane hydroxamique a action therapeutique
ES469908A1 (es) Procedimiento de utilizacion de salinomicina.
PT711163E (pt) Utilizacao de benzidamina no tratamento de estados patologicos provocados por tnf
EP0253083A3 (en) Topical vaginal use of lysine p-isobutylphenylpropionate in antiinflammatory treatment
AU1494395A (en) The use of deoxyspergualin for preparing a pharmaceutical for treating hyperreactive inflammatory diseases
IE830765L (en) GESTAGENICALLY ACTIVE 11ß-CHLORO-DELTA-15-STEROIDS
JPS5435211A (en) Vaginal suppository
Beauchene Animal model studies of therapeutic tissue expansion
吴江 Psycholinguistics: An Introduction to the Psychology of Language
JPS5430207A (en) Novel solid detergent

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee